 CRANBURY, N.J., March 5, 2021 PRNewswire -- Palatin Technologies, Inc. NYSE American: PTN, a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced that Carl... 